Results 251 to 260 of about 13,683,376 (270)

P.6.d.004 Methamphetamine cross-sensitises to stimulatory effects of modafinil on locomotor mouse behaviour

European Neuropsychopharmacology, 2012
J. Merhautová, A. Máchalová, K. Slais, A. Sulcová   +3 more
openaire   +1 more source

P.5.d.004 Behavioural changes in wistar and spontaneously hypertensive rats in kainate model of epilepsy

European Neuropsychopharmacology, 2009
J. Tchekalarova, D. Pechlivanova, P. Markova, A. Stoynev   +3 more
openaire   +1 more source

P.6.d.004 Transient inactivation of nucleus accumbens reduces morphine place preference in rats

European Neuropsychopharmacology, 2010
H. Sahraei, H. Alieig, M. Ardehari
openaire   +1 more source

P.6.d.004 Anabolic steroid misuse and opioid abstinence: experimental studies in female and male rats

European Neuropsychopharmacology, 2011
M. Vlaskovska, V. Takova, A. Tsakova, S. Surcheva, L. Kasakov   +4 more
openaire   +1 more source

P.4.d.004 Behavioural effects and parameters of oxidative stress with hecogenin in central nervous system of mice

European Neuropsychopharmacology, 2011
E. Magalhaes de Brito, R.N. Dantas Cavalcante de Abreu, J.E. Ribeiro Honório Júnior, J.M. Barbosa-Filho, F.C. Florenço de Sousa, M. Calheiros Chaves Silva, M.M. Brito Cortez Lima, G. Menezes Rabelo, M.M. França Fonteles, S.M. Mendes Vasconcelos   +9 more
openaire   +1 more source

P.3.d.004 Protective biological factors in first psychotic episode patients after antipsychotic treatment

European Neuropsychopharmacology, 2012
S. Ruiz De Azua Garcia, S. Barbeito Resa, P. Vega Perez, M. Fernandez Hernandez, P. Lopez Peña, M. Saenz Herrero, A. González-Pinto Arrillaga   +6 more
openaire   +1 more source

P.3.d.004 Sensorimotor gating of the acoustic startle response is improved by morphine in healthy human volunteers

European Neuropsychopharmacology, 2007
B.B. Quednow, P.A. Csomor, J. Chmiel, T. Beck, F.X. Vollenweider   +4 more
openaire   +1 more source

P.2.d.004 Influence of body mass index on quality of life in patients with bipolar disorder

European Neuropsychopharmacology, 2015
openaire   +1 more source

P.6.d.004 A possible role of cannabis and synthetic cannabimimetics as weight loss agents: preliminary indications

European Neuropsychopharmacology, 2015
R. Santacroce, F.S Bersani, M. Lupi, E. Cinosi, G. Martinotti, M. Di Giannantonio, L. Orsolini   +6 more
openaire   +1 more source

P.4.d.004 A comparison of the anxiolytic-like efficacy of mechanistically-distinct compounds in animal behavioural models

European Neuropsychopharmacology, 2006
D.G. Smith, T.D. Wolinsky, B. Nugent, P. Poon, N. Moore, C. Sanchez, C.J. Swanson   +6 more
openaire   +1 more source